Pre-Market Earnings Report for November 11, 2025 : SE, AU, PVLA, DAVA, BWAY, CRNT, PODC, ACCS, WKHS

Several companies are scheduled to report earnings on November 11, 2025, for the quarter ending September 30, 2025, with consensus estimates indicating a mixed outlook. Sea Limited (SE) is projected to report $0.75 EPS, a 212.50% year-over-year increase, while AngloGold Ashanti (AU) expects $1.34 EPS, up 139.29%. Conversely, Ceragon Networks (CRNT) faces a projected 73.33% decrease in EPS to $0.04, and companies like Palvella Therapeutics (PVLA), PodcastOne (PODC), and Workhorse Group (WKHS) are forecast to report negative EPS despite some showing year-over-year improvements.

Analysis

A diverse set of companies are poised to report Q3 2025 earnings, presenting a mixed outlook for investors. Sea Limited (SE) is projected to deliver robust performance with a consensus EPS of $0.75, marking a 212.50% year-over-year increase, supported by a 2025 P/E of 54.92 that implies superior growth relative to its industry's 28.40. Similarly, AngloGold Ashanti (AU) anticipates a 139.29% EPS increase to $1.34, and Brainsway (BWAY) shows strong momentum with a 175.00% EPS increase to $0.11 and a consistent track record of beating expectations.

Conversely, several firms face significant headwinds. Ceragon Networks (CRNT) is forecast to experience a 73.33% decrease in EPS to $0.04, despite a P/E of 25.89 against an industry average of 9.70. Palvella Therapeutics (PVLA), PodcastOne (PODC), and Workhorse Group (WKHS) are all expected to report negative EPS, with PVLA missing consensus by -10.26% in Q2 2025 and WKHS by -2.5% in Q1 2025.

The disparity in P/E ratios relative to industry averages highlights varied growth expectations. While SE, AU, BWAY, and DAVA exhibit higher P/E ratios, suggesting anticipated outperformance, the negative P/E ratios for PVLA (-24.32) and PODC (-13.59) underscore their current unprofitability. Investors should critically assess whether the implied growth for companies with elevated P/E multiples, particularly those with declining or negative EPS, is sustainable.

Key Decisions for Investors

• Investors should closely monitor Sea Limited (SE) and Brainsway (BWAY) for potential long opportunities, given their strong EPS growth forecasts and BWAY's consistent beat history, while acknowledging SE's high P/E.
• Exercise caution with Palvella Therapeutics (PVLA), PodcastOne (PODC), and Workhorse Group (WKHS) due to projected negative EPS and recent earnings misses, indicating fundamental challenges.
• Scrutinize companies like AngloGold Ashanti (AU) and Ceragon Networks (CRNT) where P/E ratios significantly exceed industry averages, especially CRNT with declining EPS, to ensure current valuations are justified by future growth prospects.